News

BioSpace4h
Regeneron Backs Off 23andMe, Losing Bid to Former CEO
Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...
Why is Anne Wojcicki regaining control of 23andMe and what it means for genomics firm
Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...
Regeneron CEO on 23andMe bid: Trying to balance individual privacy with biotech & genetics research
Regeneron founder, chairman and CEO Dr. Leonard Schleifer joins 'Squawk Box' to discuss the company's bid for 23andMe, ...
The Pharma Letter4h
Anne Wojcicki overcomes Regeneron in 23andMe assets battle
TTAM Research Institute, a nonprofit public benefit corporation based in California and led by 23andMe co-founder and former ...
Lohud.com, Westchester County on MSN4d
NY sues 23andMe to block sale of your genetic data to the highest bidder. What to know
New York and 27 other states sued bankrupt genetic testing company 23andMe to block the sale of 15 million customers' ...
Almost 2 million 23andMe users have asked the company to delete their data in the last 2 months
Me's Interim CEO Joe Selsavage said 1.9 million customers have asked the company delete their data since March.
STAT4d
23andMe leaders grilled on genetic data risks by federal lawmakers
The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.
Lawsuit seeks to secure ownership rights for 23andMe customers’ data
Katie Hass, director of the Utah Division of Consumer Protection, called the proposed data sale an 'egregious betrayal of ...